TransMedics (TMDX) Depreciation & Amortization (CF) (2018 - 2026)

TransMedics has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $10.3 million in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 53.73% year-over-year to $10.3 million in Q2 2026; TTM through Jun 2026 was $36.4 million, a 54.26% increase from a year earlier, with the FY2025 full-year figure at $27.2 million, up 37.59% from the prior year.
• Depreciation & Amortization (CF) was $10.3 million for Q2 2026 at TransMedics, down from $11.9 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $11.9 million in Q1 2026, with the low at $507000.0 in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $4.5 million, with a median of $4.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) advanced 13.93% in 2022, then soared 230.92% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $1.3 million in 2022, then surged by 180.54% to $3.6 million in 2023, then jumped by 57.56% to $5.7 million in 2024, then jumped by 31.48% to $7.5 million in 2025, then soared by 37.92% to $10.3 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $10.3 million (Q2 2026), $11.9 million (Q1 2026), and $7.5 million (Q4 2025), per Business Quant data.